Hindustan Biosynth Limited, a active public limited company, was established on 05 January 2004 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24231GJ2004PLC043432. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 18 professional, Its leadership includes Rahul Chandulal Limbachiya (Director), Sauhil Sudesh Bhattia (Director), Sudeshkumar Banarasidas Bhatia (Director). Past directors included Charansingh Nathasingh Chhabra, Rahul Chandulal Limbachiya, Sauhil Sudesh Bhattia. It holds ₹1.10 Cr open charges and ₹8.20 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.157,1St Floor, G.I.D.C. Industrial Estate, Por- Ramangamdi,, Vadodara, Gujarat, 391243.
U24231GJ2004PLC043432
043432
05 January 2004
₹5.00 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Hindustan Biosynth Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Chandulal Limbachiya | Director | 13 Mar 2014 | Current |
| Sauhil Sudesh Bhattia | Director | 13 Mar 2014 | Current |
| Sudeshkumar Banarasidas Bhatia | Director | 13 Mar 2014 | Current |
| Bhavesh Chandulal Limbachiya | Director | 13 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Mar 2014 | Past |
| Pramod Abcsdd | Additional Director | 22 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 19 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 19 Sep 2015 | Past |
| Pramod Abcsdd | Director | 07 Dec 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Aug 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hindustan Biosynth Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Hindustan Biosynth had a promoter holding of 99.94% and a public holding of 0.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,039,030.00
₹8,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2025 | Hdfc Bank Limited | ₹1.54 M | Open |
| 06 Apr 2023 | Hdfc Bank Limited | ₹7.50 M | Open |
| 13 Jul 2021 | Others | ₹2.00 M | Open |
| 23 Jun 2007 | Indian Bank | ₹4.20 M | Satisfied |
| 19 Mar 2007 | Indian Bank | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Hindustan Biosynth has a workforce of 18 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hindustan Biosynth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Biosynth's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 1.54 M with Charge ID 101184092 was registered on 06 Nov 2025. was recorded as a recent event.
Hindustan Biosynth Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Hindustan Biosynth Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
The activity A charge registered on 19 Mar 2007 via Charge ID 10043972 with Indian Bank was fully satisfied on 13 Apr 2023. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 7.50 M with Charge ID 100709511 was registered on 06 Apr 2023. was completed.
A charge with Others amounted to Rs. 2.00 M with Charge ID 100477003 was registered on 13 Jul 2021. was recorded as a recent event.
The CIN of Hindustan Biosynth Limited is U24231GJ2004PLC043432.
Hindustan Biosynth Limited is headquartered at Plot No.157,1St Floor, G.I.D.C. Industrial Estate, Por- Ramangamdi,, Vadodara, Gujarat, 391243.
Hindustan Biosynth Limited was incorporated on 05 January 2004.
The current directors of Hindustan Biosynth Limited are
The primary industry of Hindustan Biosynth Limited is Hospital And Medical Care.
Hindustan Biosynth Limited is unlisted.
The authorized capital of Hindustan Biosynth Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Hindustan Biosynth Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX